[P2–230]: USING CSF MARKERS TO VALIDATE METABOLIC AND SYNAPTIC DYSFUNCTION HYPOTHESES OF ALZHEIMER's DISEASE (AD): META‐ANALYSIS. (1st July 2017) - Bass, Brittany